Paperwork Reduction Act; Notice of Intent to Collect; Comment Request, 9598 [E8-3227]

Download as PDF 9598 Federal Register / Vol. 73, No. 35 / Thursday, February 21, 2008 / Notices U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. ADDRESSES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, Mail Code AL, 2101 NASA Parkway, Houston, TX 77058, (281) 483–4871; (281) 483–6936 [Facsimile]. FOR FURTHER INFORMATION CONTACT: Kurt G. Hammerle, Patent Attorney, Office of Chief Counsel, Johnson Space Center, Mail Code AL, 2101 NASA Parkway, Houston, TX 77058, (281) 483–1001; (281) 483–6936 [Facsimile]. Information about other NASA inventions available for licensing can be found online at https://technology.nasa.gov/. Dated: February 13, 2008. Keith T. Sefton, Deputy General Counsel, Administration and Management. [FR Doc. E8–3139 Filed 2–20–08; 8:45 am] BILLING CODE 7510–13–P OFFICE OF NATIONAL DRUG CONTROL POLICY Paperwork Reduction Act; Notice of Intent to Collect; Comment Request Office of National Drug Control Policy (ONDCP). ACTION: ONDCP provides opportunity for public comment concerning the collection of information to identify states that have adopted the new Healthcare Common Procedure Coding System (HCPCS) codes (Codes H0049 and H0050) for alcohol and drug screening, and brief intervention (SBI). AGENCY: pwalker on PROD1PC71 with NOTICES SUMMARY: This action proposes the collection of drug control information from state Medicaid directors. SUPPLEMENTARY INFORMATION: I. Purpose The purpose of this survey is to identify states that have adopted HCPCS codes H0049 and H0050 to permit payment of SBI services from state Medicaid programs. The information will be used as performance indicators in the Consolidated Federal Drug Control Budget and will help inform policy by providing a greater VerDate Aug<31>2005 16:34 Feb 20, 2008 Jkt 214001 understanding of the level of state participation in the SBI concept. Type of Collection: Survey of state Medicaid directors. Title of Information Collection: Healthcare Common Procedure Coding System Survey. Frequency: Annually by fiscal year. Affected Public: Instrumentalities of state Medicaid directors. Estimated Burden: Minimal since the material resides with state Medicaid directors. Wilson Blvd., Arlington, VA 22230. Telephone: 703–292–4908. Purpose of Meeting: To provide advice and recommendations to the National Science Foundation (NSF), the National Aeronautics and Space Administration (NASA) and the U.S. Department of Energy (DOE) on issues within the field of astronomy and astrophysics that are of mutual interest and concern to the agencies. Agenda: To discuss the Committee’s draft annual report due 15 March 2008. II. Special Issues for Comment Dated: February 15, 2008. Susanne E. Bolton, Committee Management Officer. [FR Doc. E8–3185 Filed 2–20–08; 8:45 am] ONDCP especially invites comments on: (a) Whether the proposed collection is necessary for the proper performance of ONDCP functions, including whether the information has practical utility; (b) ways to enhance information quality, utility, and clarity; and, (c) ways to ease the burden on respondents, including the use of automated collection techniques or other forms of information technology. ADDRESSES: Address all comments in writing 60 days to Meridith DeFraites. Facsimile and email are the more reliable means of communication. Ms. DeFraites facsimile number is (202) 395–5176, and her e-mail address is mdefraites@ondcp.eop.gov. Mailing address is Executive office of the President, Office of National Drug Control Policy, Washington, DC 20503. For further information, contact Ms. DeFraites at (202) 395–5276. Signed at Washington DC, on February 15, 2008. Daniel R. Petersen, Assistant General Counsel. [FR Doc. E8–3227 Filed 2–20–08; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 03033359] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment to Byproduct Materials License No. 37–30095–01, for Termination of the License and Unrestricted Release of MPI Research Incorporated’s Facility in State College, PA Nuclear Regulatory Commission. ACTION: Issuance of Environmental Assessment and Finding of No Significant Impact for License Amendment. AGENCY: Astronomy and Astrophysics Advisory Committee #13883; Notice of Meeting FOR FURTHER INFORMATION CONTACT: Dennis Lawyer, Health Physicist, Commercial and R&D Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale Road, King of Prussia, Pennsylvania; telephone 610–337–5366; fax number 610–337–5393; or by e-mail: drl1@nrc.gov. SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory Committee Act (Pub. L. 92– 463, as amended), the National Science Foundation announces the following Astronomy and Astrophysics Advisory Committee (#13883) meeting: Date and Time: March 10, 2008, 3 p.m.–5 p.m. EDT. Place: Teleconference, National Science Foundation, Room 1020, Stafford I Building, 4201 Wilson Blvd., Arlington, VA, 22230. Type of Meeting: Open. Contact Person: Dr. G. Wayne Van Citters, Director, Division of Astronomical Sciences, Suite 1045, National Science Foundation, 4201 I. Introduction The U.S. Nuclear Regulatory Commission (NRC) is considering the issuance of a license amendment to Byproduct Materials License No. 37– 30095–01. This license is held by MPI Research Inc. (the Licensee), for its MPI Research Inc. facility located at 3048 and 3058 Research Drive in State College, Pennsylvania (the Facility). Issuance of the amendment would authorize release of the Facility for unrestricted use and termination of the NRC license. The Licensee requested this action in a letter dated November 15, 2007. The NRC has prepared an Environmental Assessment (EA) in BILLING CODE 3180–D2–P NATIONAL SCIENCE FOUNDATION PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 73, Number 35 (Thursday, February 21, 2008)]
[Notices]
[Page 9598]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3227]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Paperwork Reduction Act; Notice of Intent to Collect; Comment 
Request

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: ONDCP provides opportunity for public comment concerning the 
collection of information to identify states that have adopted the new 
Healthcare Common Procedure Coding System (HCPCS) codes (Codes H0049 
and H0050) for alcohol and drug screening, and brief intervention 
(SBI).

-----------------------------------------------------------------------

SUMMARY: This action proposes the collection of drug control 
information from state Medicaid directors.

SUPPLEMENTARY INFORMATION: 

I. Purpose

    The purpose of this survey is to identify states that have adopted 
HCPCS codes H0049 and H0050 to permit payment of SBI services from 
state Medicaid programs. The information will be used as performance 
indicators in the Consolidated Federal Drug Control Budget and will 
help inform policy by providing a greater understanding of the level of 
state participation in the SBI concept.
    Type of Collection: Survey of state Medicaid directors.
    Title of Information Collection: Healthcare Common Procedure Coding 
System Survey.
    Frequency: Annually by fiscal year.
    Affected Public: Instrumentalities of state Medicaid directors.
    Estimated Burden: Minimal since the material resides with state 
Medicaid directors.

II. Special Issues for Comment

    ONDCP especially invites comments on: (a) Whether the proposed 
collection is necessary for the proper performance of ONDCP functions, 
including whether the information has practical utility; (b) ways to 
enhance information quality, utility, and clarity; and, (c) ways to 
ease the burden on respondents, including the use of automated 
collection techniques or other forms of information technology.

ADDRESSES: Address all comments in writing 60 days to Meridith 
DeFraites. Facsimile and email are the more reliable means of 
communication. Ms. DeFraites facsimile number is (202) 395-5176, and 
her e-mail address is mdefraites@ondcp.eop.gov. Mailing address is 
Executive office of the President, Office of National Drug Control 
Policy, Washington, DC 20503. For further information, contact Ms. 
DeFraites at (202) 395-5276.

    Signed at Washington DC, on February 15, 2008.
Daniel R. Petersen,
Assistant General Counsel.
 [FR Doc. E8-3227 Filed 2-20-08; 8:45 am]
BILLING CODE 3180-D2-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.